Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common chronic childhood disorders, and its prevalence is on the rise. National survey data from 2016 indicate that 9.4 percent of children in the United States ages 2 to 17 have had an ADHD diagnosis, including 2.4 percent of children 2 to 5 years of age. In that national survey, 8.4 percent of children ages 2 to 17 currently had ADHD, representing 5.4 million children. Among children and adolescents with current ADHD, almost two-thirds were taking medication, and approximately half had received behavioral treatment for ADHD in the past year. Nearly one quarter had received neither type of treatment of ADHD.

Symptoms of ADHD occur in childhood, and most children with ADHD will continue to have symptoms and impairment through adolescence and into adulthood. Children with ADHD may have difficulty controlling their behavior in school and social settings and often fail to achieve their full academic potential. Additionally, ADHD is frequently present with other psychiatric disorders.

La chiave per una gestione efficace a lungo termine del bambino con ADHD è la continuità delle cure con i medici esperti nel trattamento dell'ADHD. La frequenza e la durata delle sessioni di follow-up dovrebbero essere personalizzate per ogni famiglia e bambino, a seconda della gravità dei sintomi dell'ADHD; il grado di comorbilità di altre malattie psichiatriche; la risposta al trattamento; e il grado di menomazione nelle attività domestiche, scolastiche, lavorative o di pari livello.

Linee guida per la diagnosi e il trattamento

Healthcare Effectiveness Data and Information Set (HEDIS®)1 Tip Sheets

Materiali dei membri

Strumenti di screening

1 HEDIS is a registered trademark of the National Committee for Quality Assurance (NCQA).